PURPOSE: The toxicity profile of fluorouracil (5-FU)–based chemotherapy given on 5 consecutive days at doses of 370 to 450 mg/m 2 has been well documented. A meta-analysis of six North Central Cancer ...

5-Fluorouracil 4% cream achieved total clearance in 54.5% and partial clearance in 24.2% of hyperkeratotic actinic keratosis (AK) lesions at 3 months, demonstrating a good safety profile with high ...

In a phase III trial, a chemotherapy regimen of fluorouracil, oxaliplatin, and docetaxel (TFOX) improved survival outcomes over standard FOLFOX for patients with advanced HER2-negative gastric cancer.

Neoadjuvant immunotherapy for locally advanced/metastatic mismatch repair deficient colorectal cancer: A two-year institutional experience. This is an ASCO Meeting Abstract from the 2025 ASCO ...